Welcome to PsychU!

Long-Acting Injectable Adherence & Sociodemographic Characteristics Of Use

In this interview, James McCreath, PhD, Vice President of Psychiatry & Behavioral Health at the Trinitas Regional Medical Center, discusses his co-authored publication “Long-Acting Injectable Antipsychotics For Schizophrenia: Sociodemographic Characteristics & Treatment Adherence,” which published February 2017 in Primary Care Companion For CNS Disorders. Dr. McCreath shares his insights and perspectives on long-acting injectable antipsychotics (LAIs) in mental health, with Joe Cirrincione, PharmD, MBA, and Becky Wong, PharmD, MBA, members of the Otsuka Pharmaceutical Development & Commercialization, Inc. Field Medical …

Join PsychU today at no cost for access to this and other premium content!

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Specialty (select all that apply)*
Zip / Postal Code*

Choose Your Unique Login

Your username can only contain lowercase letters (a-z) and numbers.
Your password must be at least 8 characters Hint: Must use combination of lower case letters, upper case letters, numbers and special characters like !@#$.

I agree to the following terms

I agree to the following terms:*
I agree to the following terms*
Direct Care Provider
Clinician Newsletter
Management Newsletter
This field is for validation purposes and should be left unchanged.